Seminars in Colon & Rectal Surgery
Volume 17, Issue 4 , Pages 160-164 , December 2006

Receptor for Advanced Glycation Endproducts and Murine ColitisLimited Project Grant #066

  • Emina H. Huang, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Emina H. Huang, MD, 2922B Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109.

References 

  1. Dvorak HF. Tumors: wounds that do not heal (Similarities between tumor stroma generation and wound healing). N Engl J Med. 1986;315(26):1650–1659
  2. Parkin D, Pisani P, Munoz N, et al. Infections and human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999;
  3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735–6740
  4. Jess T, Loftus EV, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130(4):1039–1046
  5. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130(4):1030–1038
  6. Borm ME, He J, Kelsall B, et al. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. Gastroenterology. 2005;128(1):74–85
  7. Farmer MA, Sundberg JP, Bristol IJ, et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci USA. 2001;98(24):13820–13825
  8. Goytisolo FA, Blasco MA. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene. 2002;21(4):584–591
  9. Tanaka T, Kohno H, Suzuki R, et al. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003;94(11):965–973
  10. Rudolph U, Finegold MJ, Rich SS, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet. 1995;(2):143–150
  11. Hornquist CE, Lu X, Rogers-Fani PM, et al. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol. 1997;158(3):1068–1077
  12. Simpson SJ, Mizoguchi E, Allen D, et al. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol. 1995;(9):2618–2625
  13. Shah SA, Simpson SJ, Brown LF, et al. Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflamm Bowel Dis. 1998;4(3):196–202
  14. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature. 2004;431(7007):405–406
  15. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97(7):889–901
  16. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109(suppl):S81–S96
  17. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621–663
  18. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118(3):285–296
  19. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702
  20. Berg DJ, Davidson N, Kuhn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 1996;98(4):1010–1020

PII: S1043-1489(06)00085-6

doi: 10.1053/j.scrs.2006.10.001

Seminars in Colon & Rectal Surgery
Volume 17, Issue 4 , Pages 160-164 , December 2006

Article Tools

* Image Usage & Resolution